---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-139482"
form_type: "8-K"
ticker: "FDMT"
cik: "0001650648"
company_name: "4D Molecular Therapeutics, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T09:19:21.299623+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 4D Molecular Therapeutics closes $129.1M public offering of 8.625M shares at $16/share

## Summary
- Sold 7.5M firm shares plus 1.125M overallotment shares at $16.00 per share, netting ~$129.1M.
- Underwriters include Goldman Sachs, BofA Securities, and Evercore; lock-up restrictions until July 3, 2023.
- Offering closed on May 9, 2023; proceeds for general corporate purposes per shelf registration.

## SEC filing metadata
- accession: 0001193125-23-139482
- form_type: 8-K
- ticker: FDMT
- cik: 0001650648
- company_name: 4D Molecular Therapeutics, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/0001193125-23-139482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/d611852d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-139482
- JSON: https://secwatch.observer/filing/0001193125-23-139482.json
- Plain text: https://secwatch.observer/filing/0001193125-23-139482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.